Drug intelligence / Profile preview

adenosine + dipyridamole

Development stage
Phase 4
Lead developer
Boehringer Ingelheim
Modality
Small Molecules
Administration
Intravenous, Oral
01

Overview

The combination of adenosine and dipyridamole is a pharmacological pairing used primarily in cardiac diagnostics and treatment. ## Description Adenosine and dipyridamole represent a significant drug interaction rather than an intentional combination therapy. When used together, dipyridamole potentiates the effects of adenosine by inhibiting adenosine reuptake, resulting in increased adenosine levels and enhanced pharmacological effects[1][7]. This interaction is clinically important in several contexts: 1. **Diagnostic Applications**: The potentiation effect is utilized in cardiac stress testing, where dipyridamole enhances adenosine's vasodilatory effects for myocardial perfusion imaging[4][10]. 2. **Cardiovascular Effects**: The combination significantly increases forearm blood flow compared to adenosine alone, demonstrating dipyridamole's ability to potentiate adenosine's vasodilatory actions[4]. 3. **Potential Risks**: This combination requires careful monitoring as it can affect heart rhythm and potentially cause excessive cardiovascular effects[1][7]. 4. **Therapeutic Exploration**: Research has investigated this combination's potential benefits in conditions like schizophrenia, where a small trial showed improved outcomes when dipyridamole was added to haloperidol treatment[3].

02

Targets

ADORA1 (Adenosine receptor A1 subtype)ADORA2A (Adenosine A₂A Receptor)ADORA2B (Adenosine A2B receptor)ADORA3 (Adenosine A3 receptor)ENT1 (Solute carrier family 29 member 1)ENT2 (Equilibrative nucleoside transporter 2)PDE5 (Phosphodiesterase 5A)PDE6 (Phosphodiesterase 6)ADA (Adenosine deaminase)

Beyond the preview

Go deeper on adenosine + dipyridamole.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on adenosine + dipyridamole.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call